New Zealand markets open in 1 hour 5 minutes

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.64-0.86 (-5.55%)
As of 02:55PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close15.50
Open15.93
Bid14.74 x 1000
Ask14.81 x 800
Day's range14.61 - 15.93
52-week range11.60 - 38.43
Volume308,930
Avg. volume925,661
Market cap432.568M
Beta (5Y monthly)1.41
PE ratio (TTM)N/A
EPS (TTM)-3.28
Earnings date23 Feb 2022 - 28 Feb 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est30.00
  • Motley Fool

    3 Can't-Miss Biotech Events Coming Up in 2022

    Here's why you'll want to keep both eyes open for upcoming announcements from Alnylam Pharmaceuticals (NASDAQ: ALNY), Intercept Pharmaceuticals (NASDAQ: ICPT), and Karuna Therapeutics (NASDAQ: KRTX). Shares of Alnylam recently slipped around 15% overnight in response to a surprising clinical-trial flop for a drug it isn't even developing. Recently, BridgeBio Pharma told investors that people with heart damage caused by transthyretin amyloidosis (ATTR) who received acoramidis failed to outperform the placebo group on the six-minute walking test.

  • Zacks

    Intellia (NTLA) Inks Deal With Kyverna for Autoimmune Diseases

    Intellia (NTLA) inks a licensing and collaboration deal with Kyverna Therapeutics for developing an allogeneic CAR T-cell therapy for autoimmune diseases.

  • Motley Fool

    3 Biotech Stocks With Major Catalysts in January

    Binary events on the way could send these drugmaker stocks through the roof, or push them down in the dirt.